Sponsor

Beijing QL Biopharmaceutical Co.,Ltd

Clinical research sponsor

Published trials13
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

13 shown
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese ParticipantsNCT07550816 · lead sponsor · 2026-05-27
RECRUITING
A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy ParticipantsNCT07443059 · lead sponsor · 2026-04-13
RECRUITING
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese VolunteersNCT07184502 · lead sponsor · 2025-10-16
RECRUITING
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)NCT07812597 · lead sponsor · 2026-10-12
NOT_YET_RECRUITING
A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy AdultsNCT07697846 · lead sponsor · 2026-07-18
NOT_YET_RECRUITING
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)NCT07230119 · lead sponsor · 2026-01-16
ACTIVE_NOT_RECRUITING
Efficacy and Safety of ZT006 in Overweight and Obese ParticipantsNCT07230132 · lead sponsor · 2025-12-12
ACTIVE_NOT_RECRUITING
Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese ParticipantsNCT07307638 · lead sponsor · 2024-11-28
COMPLETED
A Study of ZT002 Injection With Subjects With Overweight or ObesityNCT07020884 · lead sponsor · 2024-08-14
COMPLETED
A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)NCT07065032 · lead sponsor · 2024-02-19
COMPLETED
A Study of ZT002 Injection in Participants With Overweight or ObesityNCT06371326 · lead sponsor · 2023-11-21
COMPLETED
A SAD Study of ZT002 Injection in Healthy ParticipantsNCT06423872 · lead sponsor · 2023-06-19
COMPLETED
A Study of ZT002 in Healthy ParticipantsNCT05491421 · collaborator · 2022-09-02
COMPLETED

Sponsor roles

lead sponsor12
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.